![PDF) Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study PDF) Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study](https://i1.rgstatic.net/publication/284185088_Asthma_is_a_risk_factor_for_new_onset_chronic_migraine_Results_from_the_American_migraine_prevalence_and_prevention_study/links/5a382e9b458515919e71ef8e/largepreview.png)
PDF) Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study
![Effect of fremanezumab on quality of life and productivity in patients with chronic migraine | Neurology Effect of fremanezumab on quality of life and productivity in patients with chronic migraine | Neurology](https://n.neurology.org/content/neurology/95/7/e878/T2.medium.gif)
Effect of fremanezumab on quality of life and productivity in patients with chronic migraine | Neurology
Montefiore Health System on LinkedIn: #montefiore #researchstudy #research #asthmacontrol #togetherwewin…
![Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study - Lipton - 2013 - Headache: The Journal of Head and Face Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study - Lipton - 2013 - Headache: The Journal of Head and Face](https://headachejournal.onlinelibrary.wiley.com/cms/asset/944d1122-f878-4640-b653-9759b7bb1779/head.2013.53.issue-10.cover.jpg)
Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study - Lipton - 2013 - Headache: The Journal of Head and Face
Relationship Between High Frequency Nausea and Treatment Satisfaction in Episodic Migraine: Results from the American Migraine P
![PDF) Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study PDF) Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study](https://i1.rgstatic.net/publication/301897008_Assessing_Barriers_to_Chronic_Migraine_Consultation_Diagnosis_and_Treatment_Results_From_the_Chronic_Migraine_Epidemiology_and_Outcomes_CaMEO_Study/links/58334ac308ae102f07368303/largepreview.png)
PDF) Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Learn how optimizing acute migraine treatment increases productivity by more than 50%. Montefiore Einstein's Dr. Richard Lipton, Director… | Instagram
![PDF) Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design PDF) Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design](https://i1.rgstatic.net/publication/320214662_Fluctuations_in_episodic_and_chronic_migraine_status_over_the_course_of_1_year_implications_for_diagnosis_treatment_and_clinical_trial_design/links/5fb92e16299bf104cf672da3/largepreview.png)
PDF) Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
![Jefferson Neurology on Twitter: "Congratulations to residency graduate and current @JeffHeadacheCtr fellow, Scott Yuan, on his award at the 2020 @ahsheadache meeting!! https://t.co/tJbp4BNFU1" / Twitter Jefferson Neurology on Twitter: "Congratulations to residency graduate and current @JeffHeadacheCtr fellow, Scott Yuan, on his award at the 2020 @ahsheadache meeting!! https://t.co/tJbp4BNFU1" / Twitter](https://pbs.twimg.com/media/ErX-QT-W8AApVA3.jpg:large)